Guardian Capital Advisors LP Eli Lilly & CO Transaction History

Guardian Capital Advisors LP

$967 Million
Q3 2024

A detailed history of Guardian Capital Advisors LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Guardian Capital Advisors LP holds 2,922 shares of LLY stock, worth $2.19 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

2,922

Previous 3,017 3.15%

Holding current value

$2.19 Million

Previous $2.73 Million 5.24%

% of portfolio

0.27%

Previous 0.31%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $73,353 - $91,201	-95 Reduced 3.15%	2,922 $2.59 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $79,735 - $99,994	-110 Reduced 3.52%	3,017 $2.73 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $355,320 - $475,368	-600 Reduced 16.1%	3,127 $2.43 Million
Q4 2023 Feb 08, 2024	BUY	$525.19 - $619.13 $6,302 - $7,429	12 Added 0.32%	3,727 $2.17 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $49,990 - $68,919	-115 Reduced 3.0%	3,715 $2 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $52,611 - $70,347	-150 Reduced 3.77%	3,830 $1.8 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $97,848 - $114,918	315 Added 8.59%	3,980 $1.37 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $25,724 - $29,973	-80 Reduced 2.14%	3,665 $1.34 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $33,447 - $39,272	-120 Reduced 3.1%	3,745 $1.22 Million
Q4 2021 Feb 10, 2022	SELL	$224.85 - $279.04 $13,491 - $16,742	-60 Reduced 1.53%	3,865 $989,000
Q2 2021 Aug 17, 2021	SELL	$180.55 - $233.54 $13,541 - $17,515	-75 Reduced 1.88%	3,925 $918,000
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $9,859 - $12,763	-60 Reduced 1.48%	4,000 $732,000
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $26,092 - $34,526	-200 Reduced 4.69%	4,060 $675,000
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $18,277 - $21,141	125 Added 3.02%	4,260 $632,000
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $36,151 - $43,507	-265 Reduced 6.02%	4,135 $492,000
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $5,346 - $6,621	-50 Reduced 1.12%	4,400 $619,000
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $10,017 - $11,791	-90 Reduced 1.98%	4,450 $513,000
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $18,532 - $20,762	-175 Reduced 3.71%	4,540 $521,000
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $28,387 - $32,580	375 Added 8.64%	4,715 $420,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $22,262 - $26,280	-300 Reduced 6.47%	4,340 $346,000
Q3 2017 Nov 15, 2017	BUY	$77.07 - $85.54 $17,340 - $19,246	225 Added 5.1%	4,640 $405,000
Q2 2017 Aug 14, 2017	BUY	N/A	4,415	4,415 $371,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Capital Advisors LP with notifications on news.

Account

Guardian Capital Advisors LP Eli Lilly & CO Transaction History